Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection

Clinical trial NCT02506842 · UNKNOWN

Trial details

NCT number

NCT02506842

Sponsor

Fudan University

Status

UNKNOWN

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2015-06-01

Primary completion

2018-12-01

Enrollment

300

View on ClinicalTrials.gov